Inlyta 5 MG Oral Tablet

RxCUI: 1243014
RxNorm name: Inlyta 5 MG Oral Tablet
Display name: Inlyta 5 MG Oral Tablet
Full name: Inlyta 5 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
INLYTA	AXITINIB	U.S. Pharmaceuticals	8a903e31-936e-4ed7-8a59-59f32374f338	2026-03-12	Warnings, Adverse reactions	Exact identifier rxcui: 1243014
INLYTA	AXITINIB	Pfizer Laboratories Div Pfizer Inc	84137882-e000-47da-bd5b-fa76ab3c76f9	2025-02-19	Warnings, Adverse reactions	Exact identifier rxcui: 1243014

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
84137882-e000-47da-bd5b-fa76ab3c76f9	Inlyta 5 MG Oral Tablet [PSN] · axitinib 5 MG Oral Tablet [Inlyta] [SBD] · Inlyta 5 MG Oral Tablet [SY]	3	24	These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA ® (axitinib) tablets, for oral administration Initial U.S. Approval: 2012	20250219
8a903e31-936e-4ed7-8a59-59f32374f338	Inlyta 5 MG Oral Tablet [PSN] · axitinib 5 MG Oral Tablet [Inlyta] [SBD] · Inlyta 5 MG Oral Tablet [SY]	3	12	These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA ® (axitinib) tablets, for oral administration Initial U.S. Approval: 2012	20260312